Comparison of the Roche Cobas® 4800 HPV assay to Digene Hybrid Capture 2, Roche Linear Array and Roche Amplicor for Detection of High-Risk Human Papillomavirus Genotypes in Women undergoing treatment for cervical dysplasia

Journal of Clinical Virology

Volumn 62, Issue , 2015, Pages 63-65

  Phillips, Samuel ^a,c   Garland, Suzanne M ^a,b,c   Tan, Jeffery H ^a,b   Quinn, Michael A ^a,b   Tabrizi, Sepehr N ^a,b,c  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

Amplicor; Diagnostic; Human papillomavirus; Hybrid capture; Linear array; Roche cobas

Indexed keywords

LANTHANUM; ANTIVIRUS AGENT; DIAGNOSTIC KIT; VIRUS DNA;

ARTICLE; ASSAY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIGENE HYBRID CAPTURE 2; FEMALE; GENOTYPE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; ROCHE AMPLICOR; ROCHE COBAS 4800 HUMAN PAPILLOMA VIRUS ASSAY; ROCHE LINEAR ARRAY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX DYSPLASIA; WART VIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DIAGNOSTIC KIT; GENETICS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; STANDARDS; UTERINE CERVICAL DYSPLASIA; VIROLOGY;

ANTIVIRAL AGENTS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REAGENT KITS, DIAGNOSTIC; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL DYSPLASIA;

EID: 84920471952     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.11.017     Document Type: Article

References (7)

1. Stoler M.H., Wright T.C., Sharma A., Zhang G., Apple R., Wright T.L., et al. The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology. Results from the ATHENA HPV study. Am J Clin Pathol 2012, 137:295-303.
2. Wright T.C., Stoler M.H., Behrens C.M., Apple R., Derion T., Wright T.L. The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol 2012, 206. 46.e1-e11.
3. Moss S.M., Bailey A., Cubie H., Denton K., Sargent A., Muir P., et al. Comparison of the performance of HPV tests in women with abnormal cytology: results of a study within the NHS cervical screening programme. Cytopathology 2014, 10.1111/cyt.12210.
4. Stevens M.P., Garland S.M., Rudland E., Tan J., Quinn M.A., Tabrizi S.N. Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J Clin Microbiol 2007, 45:2130-2137.
5. Stevens M.P., Garland S.M., Tan J.H., Quinn M.A., Petersen R.W., Tabrizi S.N. HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia. J Med Virol 2009, 81:1283-1291.
6. Mackinnon A. A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement. Comput Biol Med 2000, 30:127-134.
7. Tabrizi S.N., Stevens M.P., Khan Z.A., Chow C., Devitt M.A., Garland S.M. Comparison of PapType to Digene Hybrid Capture 2, Roche linear array, and Amplicor for detection of high-risk human papillomavirus genotypes in women with previous abnormal pap smears. J Clin Microbiol. 2012, 50:2796-2798.